During the past decade, A.S.O. S.Croce e Carle di Cuneo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "A.S.O. S.Croce e Carle di Cuneo" #1 collaborator was "University of Padova" with 2 trials as a collaborator and "Dipartimento di scienze chirurgiche, Oncologiche e Gastroenterologiche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "A.S.O. S.Croce e Carle di Cuneo" are "Breast Cancer Metastatic" (1 trials) and "Triple Negative Breast Neoplasms" (1 trials). Many other conditions were trialed in "A.S.O. S.Croce e Carle di Cuneo" in a lesser frequency.

Most popular intervention types in "A.S.O. S.Croce e Carle di Cuneo" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aromatase Inhibitors" (1 trials), "Everolimus" (1 trials) and "MSB0010718C" (1 trials). Other intervention names were less common.

The vast majority of trials in "A.S.O. S.Croce e Carle di Cuneo" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "A.S.O. S.Croce e Carle di Cuneo". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in A.S.O. S.Croce e Carle di Cuneo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in A.S.O. S.Croce e Carle di Cuneo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".